Feasibility of High Activity Rhenium-188-Microsphere in Hepatic Radioembolization
نویسندگان
چکیده
منابع مشابه
Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
BACKGROUND This paper describes the feasibility of intra-arterial high-activity administration of (188)Re-microspheres. METHODS Patients with unresectable colorectal liver metastases or hepatocellular cancer (HCC) received single treatments with (188)Re-microspheres. The administered activity was calculated to give a liver dose of 100 Gy. From post-therapeutic scans and urine sampling, the do...
متن کاملRhenium 188: The Poor Man's Yttrium
After the landmark, IAEA trial confirming the potential of intra-arterially used Re 188 Lipoidol for the treatment of inoperable hepatocellular carcinoma (HCC), it was surprising to note that none of the participating centers took this work forward. To a nonnuclear physician or scientist, it would seem baffling, but we in NM are well aware of the difficulties in instituting a new radionuclide t...
متن کاملPlanning Arteriography for Yttrium-90 Microsphere Radioembolization.
Yttrium-90 radioembolization (Y RE) is a contemporary transcatheter locoregional therapy for primary and secondary hepatic malignancies that is commonly utilized in modern Interventional Radiology (IR) practice.1 Unlike other targeted endovascular therapies, such as transarterial chemoembolization (TACE) and transarterial embolization (TAE), the current standard of care protocol for Y RE treatm...
متن کاملYttrium-90 microsphere radioembolization for hepatocellular carcinoma.
Yttrium-90 (Y90) radioembolization is an emerging strategy to treat liver malignancies, and clinical data supporting its use have accumulated in recent years. Y90-radioembolization has shown clinical effectiveness in intermediate and advanced hepatocellular carcinoma, with a favorable safety profile. Retrospective data show similar levels of effectiveness to transarterial chemoembolization in i...
متن کاملSuccessful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
Prostate cancer is the most common solid tumor malignancy worldwide with an estimated 180,000 new cases of prostate cancer and 26,000 deaths in the USA in 2016. Although significant advances in the treatment of prostate cancer have recently been made, the treatment of metastatic disease remains a challenge. With visceral metastases marking more advanced tumor stages, liver involvement is associ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Japanese Journal of Clinical Oncology
سال: 2007
ISSN: 0368-2811,1465-3621
DOI: 10.1093/jjco/hym137